SEBBIN INTEGRITY Round Implants

Launched by GROUPE SEBBIN · Nov 30, 2022

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • The patient is at least 18-year-old.
• • The patient is a woman.
• • The patient was prescribed with a surgery for a breast augmentation or reconstruction, unilaterally or bilaterally with silicone gel-filled SEBBIN INTEGRITY mammary implants.
• • The patient has been informed of the study, has read the patient information letter and provided consent in writing.
• Exclusion Criteria:
• • The patient is pregnant or breastfeeding.
• • The patient has silicone implants somewhere else than in the breast.
• * The patient was diagnosed with one of the following pathologies:
• • Systemic lupus erythematous, Sjogren syndrome, scleroderma, polymyositis, or any other connective tissue disease.
• • Rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondyloarthropathies, or any other inflammatory arthritic disease.
• • Arthritis, fibromyalgia, chronic fatigue syndrome, or any other mechanic or degenerative non-inflammatory rheumatic disease.
• • History of implant-associated anaplastic large cell lymphoma (BIA-ALCL).
• • Symptomatic autoimmune disease.
• • The patient has a pathology that could delay healing (does not apply to the reconstruction group).
• • The patient has cancer (does not apply to the reconstruction group).
• • The patient has anatomical or physiological conditions that could lead to postoperative complications.